FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “ROVIVZEL”, which is offered here for Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system;.
Its status is currently believed to be active. Its class is unavailable. “ROVIVZEL” is believed to be currently owned by “Celgene Corporation”.
| Owner: |
CELGENE CORPORATION
Owner Details |
|---|---|
| Description: |
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system;
|
| Categories: | PHARMACEUTICAL PREPARATIONS USE |